Selected settlements of federal cases involving allegations of health-care industry misconduct

PFIZER: $2.3 BILLION

Allegedly promoted unapproved uses for Bextra and other prescription drugs (September 2009)

QUEST DIAGNOSTICS: $302 MILLION

Allegedly sold inaccurate and unreliable laboratory test kits (April 2009)

ELI LILLY: $1.4 BILLION

Purportedly promoted unapproved uses for antipsychotic drug Zyprexa (January 2009)

BAYER HEALTHCARE: $97.5 MILLION

Allegedly paid kickbacks aimed at having patients switched to Bayer products (November 2008)

KYPHON: $75 MILLION

Purportedly persuaded hospitals to overbill for spinal procedures (May 2008)*

* Now owned by Medtronic

Data: U.S. Justice Dept.